Chronic obstructive pulmonary disease (COPD) may represent a serious threat

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.254, 2000-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokine Receptors in Chronic Obstructive Pulmonary Disease (COPD)

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 669-674

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD)

Current Pharmaceutical Design, Vol. 11, Iss. 16, 2005-06 ,pp. : 2053-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Ghrelin is promising for chronic obstructive pulmonary disease (COPD)-associated cachexia

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Mechanisms of Corticosteroid Resistance in Severe Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Current Pharmaceutical Design, Vol. 16, Iss. 32, 2010-11 ,pp. : 3554-3573

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Chronic Obstructive Pulmonary Disease (COPD) (Guest Editor: Alexandre Trifilieff)]

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 6, 2005-12 ,pp. : 605-605

Bentham Science Publishers

Access to resources Recommend Favorite